Brainstem abnormalities in neonates with normal otoacoustic emissions

Seminars in Hearing

Volumn 17, Issue 2, 1996, Pages 197-212

  Stein, Laszlo ^a,b,c   Tremblay, Kelly ^a   Pasternak, Joseph ^c,d   Banerjee, Shilpi ^a   Lindemann, Kari ^a   Kraus, Nina ^a,b,c  

^a Dept of Commun Sci and Disorders ^*

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUDIOLOGY; CASE REPORT; CONFERENCE PAPER; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED OTOACOUSTIC EMISSION; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; INFANT; LATENT PERIOD; MALE;

EID: 0029934342     PISSN: 07340451     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1083049     Document Type: Article

References (42)

1. Ahdab-Barmada, M., & Moossy, J. (1984). The neuropathology of kernicterus in the premature neonate: Diagnostic problems. Journal of Neuropathology and Experimental Neurology, 43, 45-56.
2. American Academy of Pediatrics. (1994). Practice parameter: Management of hyperbilirubinemia in the healthy term newborn. Pediatrics, 94, 558-565.
3. American Academy of Pediatrics. (1995). Joint Committee on Infant Hearing: 1994 Position Statement. Pediatrics, 100, 152-156.
4. Berlin, C., Hood, L., Cecola, P., Jackson, D., & Szabo, P. (1993). Does type I afferent neuron dysfunction reveal itself through lack of efferent suppression? Hearing Research, 65, 40-50.
5. Bray, P., & Kemp, D. (1987). An advanced cochlear echo technique suitable for infant screening. British Journal of Audiology, 21, 191-204.
6. Brass, D., Watkins, P., & Kemp, D. (1994). Assessment of an implementation of a narrow band, neonatal otoacoustic emission screening method. Ear and Hearing, 15, 467-475.
7. Cashore, W. (1993). Hyperbilirubinemia. In J. Pomerance & C. Ruchardson (Eds.), Neonatology for the clinician (pp. 231-241). Norwalk, CT: Appleton & Lange.
8. Chisin, R., Perlman, M., & Sohmer, H. (1979). Cochlear and brain stem hearing loss following neonatal hyperbilirubinemia. Annals of Otology, 88, 352-357.
9. Davis, H., & Hirsh, S. (1979). A slow brainstem response for low frequency audiometry. Audiology, 18, 445.
10. De Vries, L., Lary, S., Whitelaw, A., & Dubowitz, L. (1987). Relationship of serum bilirubin levels and hearing impairment in newborn infants. Early Human Development, 15, 269-277.
11. Galambos, R., Wilson, M., & Silva, P. (1994). Identifying hearing loss in the intensive care nursery: A 20-year summary. Journal American Academy of Audiology, 5, 151-162.
12. Gartner, L., Snyder, R., Chabon, R., & Bernstein, L. (1970). Kernicterus: High incidence in premature infants with low serum bilirubin concentrations. Pediatrics, 45, 906-916.
13. Gupta, A., Hans, R., & Anand, N. (1990). Auditory brainstem responses (ABR) in neonates with hyperbilirubinemia. Indian Journal of Pediatrics, 57, 705-711.
14. Jardine, D., & Rogers, K. (1989). Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants. Pediatrics, 83, 153-160.
15. Kemp, D., & Ryan, S. (1993). The use of transient evoked otoacoustic emissions in neonatal hearing screening programs. Seminars in Hearing, 14, 30-44.
16. Kemp, D., Ryan, S., & Bray, P. (1990). A guide to the effective use of otoacoustic emissions. Ear and Hearing, 11, 93-105.
17. Kraus, N., Ozdamar, O., Stein, L., & Reed, N. (1984). Absent auditory brain stem response: Peripheral hearing loss or brain stem dysfunction? Laryngoscope, 94, 400-406.
18. Kraus, N., McGee, T., Carrell, T., Ferre, J., & Hoeppner, J. (1993). Mismatch negativity in the neurophysiological/behavioral evaluation of central auditory processing deficits: A case study. Ear and Hearing, 14, 223-234.
19. Maxon, A., White, K., Vohr, B., & Behrens, T. (1993). Using transient evoked otoacoustic emissions for neonatal hearing screening. British Journal of Audiology, 27, 149-153.
20. Maxon, A., White, K., Behrens, T., & Vohr, B. (1995). Referral rates and cost efficiency in a universal newborn hearing screening program using transient evoked otoacoustic emissions, Journal of the American Academy of Audiology, 6, 271-277.
21. McGee, T., Killion, M., Rosenberg, R., & King, C. (1993). Improving the reliability of the auditory middle latency response by monitoring EEG delta activity. Ear and Hearing, 14, 76-84.
22. Nakamura, H., Takada, S., Shimabuku, R., Matsuo, M., Matsuo, T., & Negishi, H. (1985). Auditory nerve and brainstem responses in newborns with hyperbilirubinemia. Pediatrics, 75, 703-708.
23. Newman, T., & Maisels, M. (1989). Bilirubin and brain damage: What do we do now? Pediatrics, 83, 1062-1065.
24. Norton, S. (1993). Application of transient evoked otoacoustic emissions to pediatric populations. Ear and Hearing, 14, 64-73.
25. Nwaesei, C., VanAerder, J., Boyden, M., & Perlman, M. (1984). Changes in auditory brainstem responses in hyperbilirubinemia infants before and after exchange transfusion. Pediatrics, 74, 800-803.
26. NIH Consensus Statement (1993). Early identification of hearing impairment in infants and young children, 11, 1-24.
27. Perlman, M., Fainmesser, P., Sohmer, H., Tamari, H., Wax, Y., & Pevsmer, B. (1983). Auditory nerve-brainstem responses in hyperbilirubinemic neonates. Pediatrics, 72, 658-664.
28. Perlman, M., & Frank, J. (1988). Bilirubin beyond the blood-brain barrier. Pediatrics, 81, 305-315.
29. Shapiro, S. (1994). Brainstem auditory evoked potentials in an experimental model of bilirubin neurotoxicity. Clinical Pediatrics, 103, 447-453.
30. Sininger, Y., Hood, L., Starr, A., Berlin, C., & Picton, T. (1995). Hearing loss due to auditory neuropathy. Audiology Today, 7, 10-13.
31. Silver, S., Kapilulnik, J., & Sohmer, H. (1995). Contribution of asphyxia to the induction of hearing impairment in jaundiced Gunn rats. Pediatrics, 95, 579-583.
32. Starr, A., McPherson, D., Patterson, J., Don, M., Luxford, W., Shannon, R., Sininger, Y., Tonokawa, L., & Waring, M. (1991). Absence of both auditory evoked potentials and auditory percepts dependent on timing cues. Brain, 114, 1154-1180.
33. Stockard, J., & Stockard, J. (1981). Brainstem auditory evoked potentials in normal and otoneurologically impaired newborns and infants. In C. Heanry (Ed.), Current clinical neurophysiology (pp. 255-286). New York: Churchill Livingston.
34. Stockard, J., Stockard, J., Kleinberg, F., & Westmoreland, B. (1983). Prognostic value of brainstem auditory evoked potentials in neonates. Archives of Neurology, 40, 360-365.
35. van de Bor, M., van Zeben-van der Aa, T., Verloove-Vanhorick, S., Brand, R., & Ruys, J. (1989). Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: Results of a national collaborative survey. Pediatrics, 83, 915-920.
36. Vohr, B. (1990). New approaches to assessing the risks of hyperbilirubinemia. Clinics in Perinatology, 17, 293-306.
37. Vohr, B., White, K., Maxon, A., & Johnson, M. (1993). Factors affecting the interpretation of transient evoked otoacoustic emission results in neonatal screening. Seminars in Hearing, 14, 57-72.
38. Wennberg, R., Ahlfors, C., Bickers, R., McMurtry, C., & Shetter, J. (1982). Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: Improvement with exchange transfusion. Journal of Pediatrics, 100, 624-626.
39. White, K. (1995). Comments at the National Symposium on Hearing in Infants, Vail, CO.
40. White, K., & Behrens, T. (Eds.). (1993). The Rhode Island Hearing Assessment Project: Implications for universal newborn hearing screening. Seminars in Hearing, 14, 1-119.
41. Whitehead, M., Jimenez, A., Stagner, B., McCoy, M., Lonsbury-Martin, B., & Martin, G. (1995). Time windowing to improve signal-to-noise ratio of click-evoked otoacoustic emissions in adults. Abstracts Assoc Research Otolaryngology, Abstract 495.
42. Worthington, D., & Peters J. (1980). Quantifiable hearing and no ABR: Paradox or error? Ear and Hearing, 1, 281-285.